Intra Cellular Therapies reported $2.04M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Adamas Pharmaceuticals ADMS:US 527K 142K
ALKERMES ALKS:US 53.12M 12.1M
Biocryst Pharmaceuticals BCRX:US $ 0.34M 5.54M
Biogen BIIB:US $ 511.8M 52.1M
Bristol Myers Squibb BMY:US $ 2451M 52M
Esperion Therapeutics ESPR:US $ 1.8M 16K
Gilead Sciences GILD:US $ 1390M 29M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Intra Cellular Therapies ITCI:US $ 2.04M 0.58M
JAZZ PHA JAZZ:US $ 119.19M 79M
Johnson & Johnson JNJ:US $ 7250M 317M
Nektar Therapeutics NKTR:US $ 7.67M 1.91M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Novartis NVS:US $ 3754M 79M
Redhill Biopharma RDHL:US $ 10.59M 0.34M
Supernus Pharmaceuticals SUPN:US $ 25.03M 10.07M
United Therapeutics UTHR:US $ 37.2M 14.2M
Vanda Pharmaceuticals VNDA:US $ 6.57M 0.54M
Zogenix ZGNX:US $ 1.22M 0.55M